AIMC Topic: Deep Learning

Clear Filters Showing 1061 to 1070 of 26421 articles

PET and CT based DenseNet outperforms advanced deep learning models for outcome prediction of oropharyngeal cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
BACKGROUND: In the HECKTOR 2022 challenge set [1], several state-of-the-art (SOTA, achieving best performance) deep learning models were introduced for predicting recurrence-free period (RFP) in head and neck cancer patients using PET and CT images.

Deep learning-assisted cellular imaging for evaluating acrylamide toxicity through phenotypic changes.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Acrylamide (AA), a food hazard generated during thermal processing, poses significant safety risks due to its toxicity. Conventional methods for AA toxicology are time-consuming and inadequate for analyzing cellular morphology. This study developed a...

Closing the gap in plan quality: Leveraging deep-learning dose prediction for adaptive radiotherapy.

Journal of applied clinical medical physics
PURPOSE: Balancing quality and efficiency has been a challenge for online adaptive therapy. Most systems start the online re-optimization with the original planning goals. While some systems allow planners to modify the planning goals, achieving a hi...

Combining diffusion and transformer models for enhanced promoter synthesis and strength prediction in deep learning.

mSystems
UNLABELLED: In the field of synthetic biology, the engineering of synthetic promoters that outperform their natural counterparts is of paramount importance, which can optimize the expression of exogenous genes, enhance the efficiency of metabolic pat...

CPPCGM: A Highly Efficient Sequence-Based Tool for Simultaneously Identifying and Generating Cell-Penetrating Peptides.

Journal of chemical information and modeling
Cell-penetrating peptides (CPPs) are usually short oligopeptides with 5-30 amino acid residues. CPPs have been proven as important drug delivery vehicles into cells through different mechanisms, demonstrating their potential as therapeutic candidates...

Unsupervised Learning of Progress Coordinates during Weighted Ensemble Simulations: Application to NTL9 Protein Folding.

Journal of chemical theory and computation
A major challenge for many rare-event sampling strategies is the identification of progress coordinates that capture the slowest relevant motions. Machine-learning methods that can identify progress coordinates in an unsupervised manner have therefor...

Identification of heart failure subtypes using transformer-based deep learning modelling: a population-based study of 379,108 individuals.

EBioMedicine
BACKGROUND: Heart failure (HF) is a complex syndrome with varied presentations and progression patterns. Traditional classification systems based on left ventricular ejection fraction (LVEF) have limitations in capturing the heterogeneity of HF. We a...

Reducing hepatitis C diagnostic disparities with a fully automated deep learning-enabled microfluidic system for HCV antigen detection.

Science advances
Viral hepatitis remains a major global health issue, with chronic hepatitis B (HBV) and hepatitis C (HCV) causing approximately 1 million deaths annually, primarily due to liver cancer and cirrhosis. More than 1.5 million people contract HCV each yea...

MAL-Net: A Multi-Label Deep Learning Framework Integrating LSTM and Multi-Head Attention for Enhanced Classification of IgA Nephropathy Subtypes Using Clinical Sensor Data.

Sensors (Basel, Switzerland)
BACKGROUND: IgA nephropathy (IgAN) is a leading cause of renal failure, characterized by significant clinical and pathological heterogeneity. Accurate subtype classification remains challenging due to overlapping clinical manifestations and the multi...

Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer.

Scientific reports
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers known to humans. However, not all patients fare equally poor survival, and a minority of patients even survives advanced disease for months or years. Thus, there is a clinical ...